Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| basal cell | 8 studies | 30% ± 15% | |
| epithelial cell | 8 studies | 32% ± 10% | |
| goblet cell | 6 studies | 24% ± 6% | |
| enterocyte | 5 studies | 32% ± 9% | |
| secretory cell | 4 studies | 27% ± 9% | |
| club cell | 3 studies | 23% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 4 studies | 22% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 99% | 1161.55 | 646 / 653 | 98% | 49.96 | 592 / 605 |
| liver | 100% | 1992.90 | 226 / 226 | 96% | 74.44 | 391 / 406 |
| pancreas | 99% | 1167.92 | 324 / 328 | 97% | 57.50 | 172 / 178 |
| kidney | 100% | 1669.42 | 89 / 89 | 95% | 48.52 | 854 / 901 |
| prostate | 93% | 2830.87 | 227 / 245 | 100% | 121.11 | 500 / 502 |
| ovary | 94% | 873.11 | 169 / 180 | 87% | 29.01 | 376 / 430 |
| lung | 78% | 553.28 | 449 / 578 | 95% | 50.45 | 1102 / 1155 |
| stomach | 74% | 936.44 | 266 / 359 | 93% | 72.12 | 266 / 286 |
| breast | 62% | 806.04 | 283 / 459 | 97% | 51.27 | 1089 / 1118 |
| bladder | 52% | 862.86 | 11 / 21 | 96% | 94.89 | 484 / 504 |
| intestine | 51% | 2452.05 | 491 / 966 | 97% | 94.27 | 513 / 527 |
| uterus | 55% | 384.85 | 93 / 170 | 92% | 73.27 | 423 / 459 |
| adrenal gland | 100% | 1241.99 | 257 / 258 | 45% | 10.59 | 104 / 230 |
| esophagus | 41% | 1953.70 | 589 / 1445 | 97% | 51.05 | 178 / 183 |
| skin | 77% | 3285.79 | 1388 / 1809 | 58% | 16.12 | 275 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 109.29 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 18.84 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 80% | 21.03 | 64 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 34% | 10.80 | 10 / 29 |
| adipose | 28% | 160.73 | 332 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 18% | 165.89 | 166 / 929 | 0% | 0 | 0 / 0 |
| heart | 10% | 44.99 | 83 / 861 | 0% | 0 | 0 / 0 |
| brain | 1% | 4.76 | 25 / 2642 | 2% | 0.39 | 17 / 705 |
| spleen | 1% | 3.42 | 2 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 5.29 | 9 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.86 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0035591 | Molecular function | signaling adaptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | STAP2 |
| Protein name | Signal transducing adaptor family member 2 Signal-transducing adaptor protein 2 (STAP-2) (Breast tumor kinase substrate) (BRK substrate) |
| Synonyms | BKS |
| Description | FUNCTION: Substrate of protein kinase PTK6. May play a regulatory role in the acute-phase response in systemic inflammation and may modulate STAT3 activity. . |
| Accessions | ENST00000599736.5 M0R2W4 ENST00000601956.5 Q9UGK3 ENST00000594605.6 [Q9UGK3-1] M0QZ60 M0R0J5 M0QY82 ENST00000598443.5 ENST00000601482.1 ENST00000600324.5 [Q9UGK3-2] |